Treatment Options and Specialist Centers

At experienced centers, new mesothelioma cases are usually discussed at a meeting called a tumor board. Surgeons, medical oncologists, radiation oncologists, radiologists and pathologists review the scans and slides together and agree on recommendations. This matters because the right order of treatments can differ from one patient to the next. One person may start with chemotherapy or immunotherapy and have surgery later, while another may be advised against surgery altogether. The team also considers heart and lung function, other illnesses, age and what the patient wants from treatment. If you are treated close to home, you can ask whether your case has been reviewed by a team with mesothelioma experience, and whether a specialist center could weigh in before the plan is finalized.

Surgery aims to remove as much visible tumor as possible, and it is generally offered only when the disease is limited and the patient is fit enough to recover. For pleural disease, pleurectomy with decortication removes the lining and any tumor on the lung surface while keeping the lung. Extrapleural pneumonectomy, which also removes the lung, is now used more selectively. For peritoneal disease, cytoreductive surgery is often paired with heated chemotherapy delivered into the abdomen during the operation. Surgery for mesothelioma is almost always combined with other treatment. Smaller procedures also play a role for comfort, such as draining fluid, sealing the pleural space or placing a catheter. Because surgical outcomes depend heavily on experience, asking how often a surgeon performs these operations is entirely appropriate.

Medicines given through a vein are the main treatment for many patients. Chemotherapy with pemetrexed combined with cisplatin or carboplatin has been a standard for years and works by damaging cancer cells as they divide. Immunotherapy works differently. Checkpoint inhibitors such as nivolumab and ipilimumab release brakes on the immune system so it can recognize and attack cancer cells. This combination is now a common first choice for many people with pleural mesothelioma that cannot be removed, particularly those with non-epithelioid cell types. Chemotherapy and immunotherapy can also be combined in some settings. Each carries different side effects: chemotherapy is more often linked to fatigue, nausea and low blood counts, while immunotherapy can cause inflammation in organs such as the skin, bowel, thyroid or lungs.

Radiation therapy uses focused energy beams to damage cancer cells. In mesothelioma, it is often used to relieve pain or treat a specific area rather than as the main treatment, and in some centers it is part of a combined plan with surgery. Modern techniques shape the beam closely to protect the lung and other organs. Clinical trials test new drugs, combinations, surgical approaches and radiation methods. They are an important option at every stage, not only when standard treatments stop working. Eligibility rules can be strict and some trials require that certain treatments have not been given yet, which is why it helps to ask about trials early. Your team can search for trials that fit your disease type, and some trials are available at multiple sites around the country.

Treating symptoms is part of treating mesothelioma, not a separate step for later. Breathlessness can be eased by draining fluid, using medicines and learning breathing techniques. Pain can usually be well controlled with a tailored plan. Poor appetite and weight loss respond to nutrition support, which also helps people cope with surgery or chemotherapy. Pulmonary rehabilitation and gentle exercise can build strength. Palliative care teams specialize in all of this and can work alongside your oncologists from the start. Emotional support for patients and caregivers, including counseling and support groups, is also part of good care. Letting your team know early when a symptom is getting worse gives them more ways to help and can keep you well enough to continue treatment.